HEADER BIOSYNTHETIC PROTEIN 01-DEC-08 3FF0 TITLE CRYSTAL STRUCTURE OF A PHENAZINE BIOSYNTHESIS-RELATED PROTEIN (PHZB2) TITLE 2 FROM PSEUDOMONAS AERUGINOSA AT 1.90 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHENAZINE BIOSYNTHESIS PROTEIN PHZB 2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PROTEIN PHZB2 WITH CYSTATIN-LIKE FOLD AND UNKNOWN FUNCTION COMPND 5 IN PHENAZINE BIOSYNTHESIS; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS AERUGINOSA; SOURCE 3 ORGANISM_TAXID: 287; SOURCE 4 GENE: NP_250591.1, PA1900, PHZB2; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS CYSTATIN-LIKE FOLD, ANTIBIOTIC BIOSYNTHESIS, VIRULENCE, STRUCTURAL KEYWDS 2 GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN KEYWDS 3 STRUCTURE INITIATIVE, PSI-2, BIOSYNTHETIC PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 6 01-FEB-23 3FF0 1 REMARK SEQADV REVDAT 5 24-JUL-19 3FF0 1 REMARK LINK REVDAT 4 01-NOV-17 3FF0 1 REMARK REVDAT 3 13-JUL-11 3FF0 1 VERSN REVDAT 2 23-MAR-11 3FF0 1 HEADER TITLE KEYWDS REVDAT 1 16-DEC-08 3FF0 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF PROTEIN PHZB2 WITH CYSTATIN-LIKE FOLD JRNL TITL 2 AND UNKNOWN FUNCTION IN PHENAZINE BIOSYNTHESIS (NP_250591.1) JRNL TITL 3 FROM PSEUDOMONAS AERUGINOSA AT 1.90 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.50 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 41113 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.156 REMARK 3 R VALUE (WORKING SET) : 0.155 REMARK 3 FREE R VALUE : 0.181 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2061 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2836 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.63 REMARK 3 BIN R VALUE (WORKING SET) : 0.2490 REMARK 3 BIN FREE R VALUE SET COUNT : 163 REMARK 3 BIN FREE R VALUE : 0.2780 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2574 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 60 REMARK 3 SOLVENT ATOMS : 269 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 30.17 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.03 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.61000 REMARK 3 B22 (A**2) : 0.61000 REMARK 3 B33 (A**2) : -0.92000 REMARK 3 B12 (A**2) : 0.31000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.102 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.099 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.065 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.322 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.970 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.960 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2923 ; 0.016 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 2021 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3975 ; 1.475 ; 1.943 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4881 ; 0.923 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 356 ; 6.586 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 155 ;36.252 ;23.613 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 465 ;14.377 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;16.510 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 390 ; 0.088 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3370 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 656 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 512 ; 0.214 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2193 ; 0.205 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1355 ; 0.186 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1561 ; 0.083 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 220 ; 0.174 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 9 ; 0.131 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 46 ; 0.290 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 18 ; 0.206 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1860 ; 2.112 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 686 ; 0.521 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2775 ; 2.587 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1355 ; 4.885 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1200 ; 6.238 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 13 A 161 6 REMARK 3 1 B 13 B 161 6 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 LOOSE POSITIONAL 1 A (A): 2049 ; 0.400 ; 5.000 REMARK 3 LOOSE THERMAL 1 A (A**2): 2049 ; 3.160 ;10.000 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 0 A 161 REMARK 3 ORIGIN FOR THE GROUP (A): 75.0324 39.2614 11.4631 REMARK 3 T TENSOR REMARK 3 T11: -0.0893 T22: 0.0466 REMARK 3 T33: -0.0501 T12: -0.0070 REMARK 3 T13: 0.0248 T23: -0.0240 REMARK 3 L TENSOR REMARK 3 L11: 1.3371 L22: 1.2675 REMARK 3 L33: 1.3131 L12: 0.5854 REMARK 3 L13: -0.0127 L23: -0.1178 REMARK 3 S TENSOR REMARK 3 S11: -0.1382 S12: 0.2910 S13: -0.0663 REMARK 3 S21: -0.1161 S22: 0.1200 S23: -0.2072 REMARK 3 S31: 0.1241 S32: 0.2191 S33: 0.0182 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 9 B 162 REMARK 3 ORIGIN FOR THE GROUP (A): 57.2319 40.3942 21.8388 REMARK 3 T TENSOR REMARK 3 T11: -0.1015 T22: -0.0741 REMARK 3 T33: -0.0797 T12: -0.0024 REMARK 3 T13: -0.0097 T23: 0.0031 REMARK 3 L TENSOR REMARK 3 L11: 1.0913 L22: 1.0886 REMARK 3 L33: 1.6442 L12: 0.1562 REMARK 3 L13: 0.1114 L23: -0.3875 REMARK 3 S TENSOR REMARK 3 S11: -0.0618 S12: 0.0320 S13: 0.0889 REMARK 3 S21: 0.0044 S22: 0.0668 S23: 0.0951 REMARK 3 S31: 0.0026 S32: -0.0638 S33: -0.0050 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. 2. ATOM RECORDS CONTAIN RESIDUAL B FACTORS REMARK 3 ONLY. 3. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE REMARK 3 ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 FOR THE REDUCED REMARK 3 SCATTERING POWER DUE TO PARTIAL S-MET INCORPORATION. 4. THERE IS REMARK 3 UNIDENTIFIED DENSITY FOUND NEAR THE ACTIVE SITE. IT WAS MODELED REMARK 3 AS AN UNKNOWN LIGAND (UNL). THE DENSITY IS SIMILAR IN SHAPE TO REMARK 3 NITROBENZENE OR BENZOIC ACID. 5. GLYCEROL (GOL) MOLECULES FROM REMARK 3 CRYO SOLUTION ARE MODELED. REMARK 4 REMARK 4 3FF0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-DEC-08. REMARK 100 THE DEPOSITION ID IS D_1000050508. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-OCT-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 10.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.94645,0.97967 REMARK 200 MONOCHROMATOR : SI(111) DOUBLE CRYSTAL REMARK 200 MONOCHROMETER REMARK 200 OPTICS : ADJUSTABLE FOCUSING MIRRORS IN K REMARK 200 -B GEOMETRY REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41139 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 28.502 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 7.500 REMARK 200 R MERGE (I) : 0.07800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.7400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.80700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.8000M K2HPO4, 0.2000M LI2SO4, REMARK 280 1.2000M NAH2PO4, 0.1M CAPS PH 10.5, NANODROP, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.75333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 26.87667 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 26.87667 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 53.75333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7750 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13310 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -37.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 162 REMARK 465 GLY B 0 REMARK 465 MSE B 1 REMARK 465 LEU B 2 REMARK 465 ASP B 3 REMARK 465 ASN B 4 REMARK 465 ALA B 5 REMARK 465 ILE B 6 REMARK 465 PRO B 7 REMARK 465 GLN B 8 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 11 CD OE1 OE2 REMARK 470 GLU A 15 CG CD OE1 OE2 REMARK 470 ARG A 18 CD NE CZ NH1 NH2 REMARK 470 LYS A 26 CE NZ REMARK 470 LYS A 31 NZ REMARK 470 ARG A 37 NE CZ NH1 NH2 REMARK 470 LYS A 131 CE NZ REMARK 470 LYS A 133 CE NZ REMARK 470 LYS A 156 CD CE NZ REMARK 470 GLU A 158 CG CD OE1 OE2 REMARK 470 GLU B 11 CD OE1 OE2 REMARK 470 GLU B 15 CG CD OE1 OE2 REMARK 470 LYS B 26 CE NZ REMARK 470 LYS B 66 CE NZ REMARK 470 GLN B 154 CD OE1 NE2 REMARK 470 LYS B 156 CD CE NZ REMARK 470 GLU B 158 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MSE A 1 CG - SE - CE ANGL. DEV. = 27.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 157 62.20 -109.25 REMARK 500 ARG B 157 75.83 -111.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UNL A 163 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UNL A 164 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 165 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 166 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 167 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 168 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 163 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 164 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 165 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 391122 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING REMARK 999 ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 3FF0 A 1 162 UNP Q9S508 PHZB2_PSEAE 1 162 DBREF 3FF0 B 1 162 UNP Q9S508 PHZB2_PSEAE 1 162 SEQADV 3FF0 GLY A 0 UNP Q9S508 EXPRESSION TAG SEQADV 3FF0 GLY B 0 UNP Q9S508 EXPRESSION TAG SEQRES 1 A 163 GLY MSE LEU ASP ASN ALA ILE PRO GLN GLY PHE GLU ASP SEQRES 2 A 163 ALA VAL GLU LEU ARG ARG LYS ASN ARG GLU THR VAL VAL SEQRES 3 A 163 LYS TYR MSE ASN THR LYS GLY GLN ASP ARG LEU ARG ARG SEQRES 4 A 163 HIS GLU LEU PHE VAL GLU ASP GLY CYS GLY GLY LEU TRP SEQRES 5 A 163 THR THR ASP THR GLY SER PRO ILE VAL ILE ARG GLY LYS SEQRES 6 A 163 ASP LYS LEU ALA GLU HIS ALA VAL TRP SER LEU LYS CYS SEQRES 7 A 163 PHE PRO ASP TRP GLU TRP TYR ASN ILE LYS VAL PHE GLU SEQRES 8 A 163 THR ASP ASP PRO ASN HIS PHE TRP VAL GLU CYS ASP GLY SEQRES 9 A 163 HIS GLY LYS ILE LEU PHE PRO GLY TYR PRO GLU GLY TYR SEQRES 10 A 163 TYR GLU ASN HIS PHE LEU HIS SER PHE GLU LEU ASP ASP SEQRES 11 A 163 GLY LYS ILE LYS ARG ASN ARG GLU PHE MSE ASN VAL PHE SEQRES 12 A 163 GLN GLN LEU ARG ALA LEU SER ILE PRO VAL PRO GLN ILE SEQRES 13 A 163 LYS ARG GLU GLY ILE PRO THR SEQRES 1 B 163 GLY MSE LEU ASP ASN ALA ILE PRO GLN GLY PHE GLU ASP SEQRES 2 B 163 ALA VAL GLU LEU ARG ARG LYS ASN ARG GLU THR VAL VAL SEQRES 3 B 163 LYS TYR MSE ASN THR LYS GLY GLN ASP ARG LEU ARG ARG SEQRES 4 B 163 HIS GLU LEU PHE VAL GLU ASP GLY CYS GLY GLY LEU TRP SEQRES 5 B 163 THR THR ASP THR GLY SER PRO ILE VAL ILE ARG GLY LYS SEQRES 6 B 163 ASP LYS LEU ALA GLU HIS ALA VAL TRP SER LEU LYS CYS SEQRES 7 B 163 PHE PRO ASP TRP GLU TRP TYR ASN ILE LYS VAL PHE GLU SEQRES 8 B 163 THR ASP ASP PRO ASN HIS PHE TRP VAL GLU CYS ASP GLY SEQRES 9 B 163 HIS GLY LYS ILE LEU PHE PRO GLY TYR PRO GLU GLY TYR SEQRES 10 B 163 TYR GLU ASN HIS PHE LEU HIS SER PHE GLU LEU ASP ASP SEQRES 11 B 163 GLY LYS ILE LYS ARG ASN ARG GLU PHE MSE ASN VAL PHE SEQRES 12 B 163 GLN GLN LEU ARG ALA LEU SER ILE PRO VAL PRO GLN ILE SEQRES 13 B 163 LYS ARG GLU GLY ILE PRO THR MODRES 3FF0 MSE A 1 MET SELENOMETHIONINE MODRES 3FF0 MSE A 28 MET SELENOMETHIONINE MODRES 3FF0 MSE A 139 MET SELENOMETHIONINE MODRES 3FF0 MSE B 28 MET SELENOMETHIONINE MODRES 3FF0 MSE B 139 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 28 8 HET MSE A 139 8 HET MSE B 28 8 HET MSE B 139 8 HET UNL A 163 9 HET UNL A 164 9 HET GOL A 165 6 HET GOL A 166 6 HET GOL A 167 6 HET GOL A 168 6 HET GOL B 163 6 HET GOL B 164 6 HET GOL B 165 6 HETNAM MSE SELENOMETHIONINE HETNAM UNL UNKNOWN LIGAND HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 MSE 5(C5 H11 N O2 SE) FORMUL 5 GOL 7(C3 H8 O3) FORMUL 12 HOH *269(H2 O) HELIX 1 1 GLY A 0 ASN A 4 5 5 HELIX 2 2 ALA A 13 ASN A 29 1 17 HELIX 3 3 LYS A 31 GLU A 40 5 10 HELIX 4 4 GLY A 63 PHE A 78 1 16 HELIX 5 5 ASN A 140 LEU A 148 1 9 HELIX 6 6 GLY B 9 THR B 30 1 22 HELIX 7 7 LYS B 31 GLU B 40 5 10 HELIX 8 8 GLY B 63 PHE B 78 1 16 HELIX 9 9 ASN B 140 LEU B 148 1 9 SHEET 1 A 6 ILE A 59 ARG A 62 0 SHEET 2 A 6 PHE A 42 LEU A 50 -1 N GLY A 48 O ILE A 61 SHEET 3 A 6 LYS A 131 MSE A 139 1 O GLU A 137 N GLY A 49 SHEET 4 A 6 GLY A 115 ASP A 128 -1 N GLU A 126 O LYS A 133 SHEET 5 A 6 HIS A 96 ILE A 107 -1 N CYS A 101 O PHE A 121 SHEET 6 A 6 GLU A 82 GLU A 90 -1 N PHE A 89 O TRP A 98 SHEET 1 B 6 ILE B 59 ARG B 62 0 SHEET 2 B 6 PHE B 42 LEU B 50 -1 N GLY B 48 O ILE B 61 SHEET 3 B 6 LYS B 131 MSE B 139 1 O GLU B 137 N GLY B 49 SHEET 4 B 6 GLY B 115 ASP B 128 -1 N GLU B 126 O LYS B 133 SHEET 5 B 6 HIS B 96 ILE B 107 -1 N CYS B 101 O PHE B 121 SHEET 6 B 6 GLU B 82 GLU B 90 -1 N PHE B 89 O TRP B 98 LINK C GLY A 0 N MSE A 1 1555 1555 1.33 LINK C MSE A 1 N LEU A 2 1555 1555 1.34 LINK C TYR A 27 N MSE A 28 1555 1555 1.34 LINK C MSE A 28 N ASN A 29 1555 1555 1.33 LINK C PHE A 138 N MSE A 139 1555 1555 1.31 LINK C MSE A 139 N ASN A 140 1555 1555 1.33 LINK C TYR B 27 N MSE B 28 1555 1555 1.33 LINK C MSE B 28 N ASN B 29 1555 1555 1.33 LINK C PHE B 138 N MSE B 139 1555 1555 1.32 LINK C MSE B 139 N ASN B 140 1555 1555 1.33 SITE 1 AC1 7 PHE A 109 GLN A 144 GOL A 166 GOL A 167 SITE 2 AC1 7 HOH A 210 ARG B 157 ILE B 160 SITE 1 AC2 7 ARG A 157 HOH A 180 HIS B 70 PHE B 109 SITE 2 AC2 7 GLN B 144 GOL B 163 GOL B 165 SITE 1 AC3 9 TYR A 116 TYR A 117 GLU A 118 GLN A 143 SITE 2 AC3 9 ARG A 146 ALA A 147 HOH A 231 THR B 55 SITE 3 AC3 9 GLY B 56 SITE 1 AC4 9 SER A 74 PHE A 78 TRP A 81 PHE A 121 SITE 2 AC4 9 GLU A 137 UNL A 163 HOH A 171 HOH A 210 SITE 3 AC4 9 HOH A 256 SITE 1 AC5 10 TYR A 27 PHE A 42 GLY A 49 ILE A 61 SITE 2 AC5 10 LEU A 67 HIS A 70 ASN A 135 GLU A 137 SITE 3 AC5 10 UNL A 163 HOH A 331 SITE 1 AC6 9 ASP A 92 HOH A 200 HOH A 303 LYS B 87 SITE 2 AC6 9 VAL B 88 LYS B 131 HOH B 243 HOH B 260 SITE 3 AC6 9 HOH B 261 SITE 1 AC7 11 UNL A 164 TYR B 27 ARG B 38 PHE B 42 SITE 2 AC7 11 GLY B 48 GLY B 49 HIS B 70 ASN B 135 SITE 3 AC7 11 GLU B 137 HOH B 241 HOH B 268 SITE 1 AC8 4 THR B 30 ASP B 34 ARG B 37 GLU B 40 SITE 1 AC9 8 UNL A 164 HOH A 180 SER B 74 TRP B 81 SITE 2 AC9 8 PHE B 121 GLU B 137 HOH B 235 HOH B 240 CRYST1 105.540 105.540 80.630 90.00 90.00 120.00 P 32 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009475 0.005470 0.000000 0.00000 SCALE2 0.000000 0.010941 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012402 0.00000